Journal
PHARMACOLOGICAL RESEARCH
Volume 99, Issue -, Pages 337-343Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2015.07.015
Keywords
Skin; Connexin; Genetic disease; Inhibitor; Gap junctions; KID syndrome; Inflammation
Categories
Funding
- NIH grant from the NIAMS [R01 AR59505]
Ask authors/readers for more resources
Connexin mutations underlie numerous human genetic diseases. Several connexin genes have been linked to skin diseases, and mechanistic studies have indicated that a gain of abnormal channel function may be responsible for pathology. The topical accessibility of the epidermal connexins, the existence of several mouse models of human skin disease, and the ongoing identification of pharmacological inhibitors targeting connexins provide an opportunity to test new therapeutic approaches. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available